11:09 09/15 UTC — Mixed
U.S. broad market futures are stabilizing off overnight lows as intraday buying algorithms attempt to offset rising Treasury yields and inflation worries. Ticker-specific fundamental news is driving outsized moves, highlighted by blowout earnings guidance from Forgent Power Solutions and strong Phase 3 trial results from Vera Therapeutics. Overall sentiment remains cautious and mixed ahead of upcoming macroeconomic policy events.
U.S. market index futures are recovering from pre-market lows despite macro headwinds driven by elevated Treasury yields near 5% and rising energy costs. Trader sentiment remains split between macroeconomic rate path concerns and strong idiosyncratic company catalysts. Dip-buying algorithms and earnings beats are keeping index losses in check, creating a highly selective trading environment focused on stock-specific news.
Outlook
Mixed · Intraday (Medium)
Base — Likely
Indices trade sideways in a choppy range as pre-market dip buying offsets persistent pressure from high Treasury yields.
Bull — Possible
A pullback in bond yields triggers a momentum rally across big tech and growth equities.
Bear — Unlikely
Rising oil and yield spikes re-accelerate selling pressure into the regular session open.
Hot tickers
- FPS Bullish — Reported record Q4 revenue of $462M (up 94.3% YoY), GAAP EPS of $0.25, a $3.0B backlog, and raised FY2027 guidance.
- VERA Bullish — Announced positive 2-year ORIGIN 3 trial results showing TRUTAKNA stabilized kidney function and reduced progression risk by 76%, supporting full FDA filing.
- RKLB Neutral — Fully funded its Iridium acquisition through a $1.94B ATM completion, credit amendment, and bridge facility termination.
- ORCL Mixed — Intense market debate over high FY2027 CapEx and negative free cash flow versus strong long-term AI infrastructure revenue potential.
- TFC Bullish — Selling $5.5B in auto loans for $5.2B net proceeds to boost CET1 capital by $945M.
Themes
- Macro Rate & Yield Pressures vs. Intraday Dip Buying
- Strong Micro Fundamental Catalysts (Earnings & Biotech Data)
- Corporate Restructuring and Balance Sheet Financing
Risks
- 10-Year Treasury Yield holding near 17-year highs above 5%
- Persistently high energy prices and inflation expectations
- High short interest in volatility-driven biotech and growth equities
Get digest by email Open live dashboard All digests About FC Global